-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NImoWFACgkmMsa/B4ffeVotDuSWF7mDjo6OYZviah9/89aLulOfrRSJviVEyyW9E k14AjSDtDdft0I9A0hzwUg== 0001045463-98-000004.txt : 19980427 0001045463-98-000004.hdr.sgml : 19980427 ACCESSION NUMBER: 0001045463-98-000004 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19980424 SROS: NASD SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: CELGENE CORP /DE/ CENTRAL INDEX KEY: 0000816284 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222711928 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D SEC ACT: SEC FILE NUMBER: 005-39368 FILM NUMBER: 98600450 BUSINESS ADDRESS: STREET 1: 7 POWDER HORN DR CITY: WARREN STATE: NJ ZIP: 07059 BUSINESS PHONE: 9082711001 MAIL ADDRESS: STREET 1: 7 POWDER HORN DRIVE STREET 2: P O BOX 4914 CITY: WARREN STATE: NJ ZIP: 07059 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: SCULLY WILLIAM P CENTRAL INDEX KEY: 0001045463 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13D BUSINESS ADDRESS: STREET 1: P O BOX 357 STREET 2: ONE MAIN ST CITY: CHATHAM STATE: NJ ZIP: 07928 MAIL ADDRESS: STREET 1: C/O MCGRATH DOYLE & PHAIR STREET 2: 150 BROADWAY CITY: NEW YORK STATE: NY ZIP: 10038 SC 13D 1 AMENDED United States Securities and Exchange Commission Washington, DC 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 CELGENE CORP. (Name Of Issuer) Common (Title of Class of Securities) 151020104 (CUSIP Number) Donald P. Moriarty and/or William P. Scully c/o McGrath, Doyle & Phair 150, Broadway, Suite 1703 New York, NY 10038 Telephone: (212) 571-2300 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) 3/24/98 (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement of Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13-1d(b)(3) or (4), check the following box [ ]. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes.) SCHEDULE 13D page 2 of 4 pages 1. NAME OF REPORTING PERSON Donald P. Moriarty and/or William P. Scully SS OR IRS IDENTIFICATION NO. OF THE ABOVE PERSON 2. CHECK THE APPROPRIATE BOX IF A Controls voting and dispositive (a)[x] MEMBER OF A GROUP power for himself, his family (b)[ ] members and a partnership in which he and his partner are general partners. 3. SEC USE ONLY 4. SOURCE OF FUNDS PF 5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS [ ] (IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E) 6. CITIZENSHIP OR PLACE OF ORGANIZATION USA NUMBER OF 7. SOLE VOTING POWER 1,355,500 SHARES BENEFICIALLY 8. SHARED VOTING POWER OWNED BY EACH 9. SOLE DISPOSITIVE POWER 1,355,500 REPORTING PERSON WITH 10. SHARED DISPOSITIVE POWER 11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH 1,355,500 REPORTING PERSON 12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) [ ] EXCLUDES CERTAIN SHARES 13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 8.4766% 14. TYPE OF REPORTING PERSON IN SCHEDULE 13D page 3 of 4 pages Item 1. Security and Issuer. a) Name and Address of Principal Executive Officers of Issuer: Celegene Corp. 7 Powderhorn Drive Warren, NJ 07059 (b) Title and class of Common Stock Equity Securities: Item 2. Identity and Background. (a) Name of Person Filing Donald P. Moriarty and/or William P. Scully (b) State of Incorporation: N/A (c) Principal of Business: Investment Advisor, Twin Oaks Partners One Main Street Chatham, NJ 07928 (d) Address of Principal Business and Principal Office: c/o McGrath, Doyle & Phair 150 Broadway, # 1703 New York, NY 10038 (e) Criminal Proceedings: N/A (f) Civil Proceedings: N/A SCHEDULE 13D page 4 of 4 pages Item 3. Source and Amount of Funds or other Consideration. Personal Funds - $1,029,983 paid for additional purchases Item 4. Purpose of Transaction. Material acquisition for investment purposes Item 5. Interests in Securities of the Issuer. (a) Number of Shares 1,355,500 shares Beneficially Owned: Percent of Class: 8.4766% (b) Sole Power to Vote, Direct the Vote of, or 1,355,500 shares Dispose of Shares: Shared Power to Vote, Direct the Vote of, or None Dispose of Shares: (c) Recent Transactions: Investor acquired approximately an additional 0.195% of the common shares outstanding since the last filing of Schedule 13D. However, please note that the company issued additional shares since the last Schedule 13D filing which diluted the investors holdings. (d) Rights to Dividends or Sales Proceeds: N/A (e) Date of Cessation of Five Percent Beneficial Ownership: N/A Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer. N/A Item 7. Material to be Filed as Exhibits. N/A Nicholas Jacangelo, CPA -----END PRIVACY-ENHANCED MESSAGE-----